Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28903334)

  • 1. Base excision repair imbalance in colorectal cancer has prognostic value and modulates response to chemotherapy.
    Leguisamo NM; Gloria HC; Kalil AN; Martins TV; Azambuja DB; Meira LB; Saffi J
    Oncotarget; 2017 Aug; 8(33):54199-54214. PubMed ID: 28903334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.
    Liu L; Taverna P; Whitacre CM; Chatterjee S; Gerson SL
    Clin Cancer Res; 1999 Oct; 5(10):2908-17. PubMed ID: 10537360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
    Jover R; Zapater P; Castells A; Llor X; Andreu M; Cubiella J; Piñol V; Xicola RM; Bujanda L; Reñé JM; Clofent J; Bessa X; Morillas JD; Nicolás-Pérez D; Payá A; Alenda C;
    Gut; 2006 Jun; 55(6):848-55. PubMed ID: 16299036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of changes in base excision repair machinery in sporadic colorectal cancer.
    Azambuja DB; Leguisamo NM; Gloria HC; Kalil AN; Rhoden E; Saffi J
    Pathol Res Pract; 2018 Jan; 214(1):64-71. PubMed ID: 29254784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined analysis of mismatch repair status and thymidylate synthase expression in stage II and III colon cancer.
    Öhrling K; Karlberg M; Edler D; Hallström M; Ragnhammar P
    Clin Colorectal Cancer; 2013 Jun; 12(2):128-35. PubMed ID: 23276521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Base excision repair capacity as a determinant of prognosis and therapy response in colon cancer patients.
    Vodenkova S; Jiraskova K; Urbanova M; Kroupa M; Slyskova J; Schneiderova M; Levy M; Buchler T; Liska V; Vodickova L; Vymetalkova V; Collins A; Opattova A; Vodicka P
    DNA Repair (Amst); 2018 Dec; 72():77-85. PubMed ID: 30314738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer.
    Jaiswal AS; Banerjee S; Aneja R; Sarkar FH; Ostrov DA; Narayan S
    PLoS One; 2011 Feb; 6(2):e16691. PubMed ID: 21311763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer.
    Ohrling K; Edler D; Hallström M; Ragnhammar P
    Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An association selected polymorphisms of XRCC1, OGG1 and MUTYH gene and the level of efficiency oxidative DNA damage repair with a risk of colorectal cancer.
    Przybylowska K; Kabzinski J; Sygut A; Dziki L; Dziki A; Majsterek I
    Mutat Res; 2013; 745-746():6-15. PubMed ID: 23618615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency.
    Castells A; Payá A; Alenda C; Rodríguez-Moranta F; Agrelo R; Andreu M; Piñol V; Castellví-Bel S; Jover R; Llor X; Pons E; Elizalde JI; Bessa X; Alcedo J; Saló J; Medina E; Naranjo A; Esteller M; Piqué JM;
    Clin Cancer Res; 2006 Mar; 12(6):1686-92. PubMed ID: 16551850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.
    Bendardaf R; Lamlum H; Ristamäki R; Korkeila E; Syrjänen K; Pyrhönen S
    Acta Oncol; 2008; 47(6):1046-53. PubMed ID: 17943475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O6-methylguanine-DNA methyltransferase activity.
    Pagani E; Falcinelli S; Pepponi R; Turriziani M; Caporaso P; Caporali S; Bonmassar E; D'Atri S
    Int J Oncol; 2007 Feb; 30(2):443-51. PubMed ID: 17203227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced host cell reactivation of oxidative DNA damage in human cells deficient in the mismatch repair gene hMSH2.
    Pitsikas P; Lee D; Rainbow AJ
    Mutagenesis; 2007 May; 22(3):235-43. PubMed ID: 17351251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of adenomatous polyposis coli-induced blockade of base excision repair pathway in colorectal carcinogenesis.
    Narayan S; Sharma R
    Life Sci; 2015 Oct; 139():145-52. PubMed ID: 26334567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional, genetic, and epigenetic aspects of base and nucleotide excision repair in colorectal carcinomas.
    Slyskova J; Korenkova V; Collins AR; Prochazka P; Vodickova L; Svec J; Lipska L; Levy M; Schneiderova M; Liska V; Holubec L; Kumar R; Soucek P; Naccarati A; Vodicka P
    Clin Cancer Res; 2012 Nov; 18(21):5878-87. PubMed ID: 22966016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carmustine-resistant cancer cells are sensitized to temozolomide as a result of enhanced mismatch repair during the development of carmustine resistance.
    Yamauchi T; Ogawa M; Ueda T
    Mol Pharmacol; 2008 Jul; 74(1):82-91. PubMed ID: 18430789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancer.
    Bendardaf R; Lamlum H; Ristamäki R; Syrjänen K; Pyrhönen S
    Oncol Rep; 2008 Nov; 20(5):999-1004. PubMed ID: 18949393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency.
    Jensen LH; Lindebjerg J; Byriel L; Kolvraa S; Crüger DG
    Colorectal Dis; 2008 Jun; 10(5):490-7. PubMed ID: 17868408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status.
    Adamsen BL; Kravik KL; De Angelis PM
    Int J Oncol; 2011 Sep; 39(3):673-82. PubMed ID: 21674128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
    Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.